Indicationstatement

Indicationstatement is a term used to describe the portion of medical labeling or documentation that specifies the medical conditions, diseases, or patient populations for which a drug, device, or procedure is approved or recommended. It is intended to guide clinicians and patients in determining when a product should be used and to support safe and effective prescribing.

In regulatory labeling, the indication statement is typically part of the indications and usage section. It must be supported by clinical data and regulatory review, and it may define conditions by disease state, age group, or disease severity. Indication statements can be broad or narrow, and they may be revised through labeling amendments as new evidence emerges. They are central to aligning clinical practice with approved uses and to regulating promotional claims.

In practice, the indication statement helps distinguish approved uses from off-label use. Clinicians should generally use products only within the stated indications, and marketing materials are expected to reflect approved indications rather than broader claims. The statement also supports health information systems by providing a clear, machine-readable description of approved uses. In data models or electronic health records, the field may be labeled as indicationstatement to capture this information in a standardized form.

Indication statements are distinct from contraindications, warnings, and adverse effects, which describe conditions under which use is inappropriate or risky. They form a foundational element of drug labeling, clinical guidelines, and regulatory compliance.

See also: indications (pharmacology), drug labeling, regulatory affairs, contraindication.